Nigerian tycoon Fidelis Ayebae’s Fidson achieves revenue exceeding $37 million in 2023
The surge in revenue is linked to the heightened sales of ethical products, including infusions, capsules, and tablets.
Fidson Healthcare
Nigerian tycoon Fidelis Ayebae gains $1.1 million from Fidson stake
Ayebae, a banker turned accomplished industrialist, owns a 33.1-percent stake in the pharmaceutical company, which translates to 759,643,749 ordinary shares.
Nigerian tycoon Fidelis Ayebae gains $1.4 million from investment in Fidson
The recent gains solidify Ayebae’s position as one of Africa’s pharmaceutical industry magnates.
Nigerian tycoon Fidelis Ayebae loses over $1 million from Fidson stake
Ayebae owns an impressive 33.1-percent stake in Fidson Healthcare.
Nigerian pharma tycoon Fidelis Ayebae’s Fidson smashes expectations with $9.08-million profit
Fidson Healthcare has established itself as a leading player in the Nigerian and West African pharmaceutical industries.